Merck Greece's Susan King-Barnardo outlines how she navigated the affiliate through the challenging waters of COVID-19, the unique market access challenges that innovative pharma is facing in Greece, Merck's burgeoning clinical trial footprint in the country, and her approach to fostering diversity, equity, and inclusion.
There is a lot to be optimistic about in Greece. For example, the implementation of a digital app and vaccination certificate during COVID-19 worked very well. Moreover, Greece’s electronic drug approval system is fantastic
